Lux Health Tech Acquisition Corp. (LUXA.U) Prices $300M IPO

Lux Health Tech Acquisition Corp. announced the pricing of its $300 million IPO and its units are expected to begin trading on the NYSE under the symbol “LUXA.U” tomorrow, Tuesday, October 27.

The new company aims to combine with a healthcare technology target with an experienced management team of serial entrepreneurs and acclaimed scientists. Lux Health is led by Chairman Peter Hébert, CEO and Director Josh DeFonzo and CFO and Treasurer Segolene Scarborough.

Total SPAC deal count for 2020 year-to-date is now 161 with $59.36 billion in gross proceeds raised. This offering is expected to close on Thursday, October 29.

Credit Suisse Securities (USA) LLC is acting as sole book-running manager for the offering and Stifel, Nicolaus & Company, Incorporated is acting as lead manager. Latham & Watkins LLP is serving as Issuer’s Counsel with Paul Hastings LLP serving as Underwriter’s Counsel. Marcum LLP serves as auditor. Continental Stock Transfer & Trust Company LLC is acting as trustee.